Intrinsiqs

Is Century Therapeutics, Inc. overvalued?

Century Therapeutics, Inc. (IPSC) — key valuation metrics and fundamentals.

No verdict
Price
$1.67
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$144.6M
Dividend yield
0.0%
Return on equity
-52.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IPSC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.